acetaminophen, guaifenesin, pseudoephedrine hcl, dextromethorphan hbr
acetaminophen, guaifenesin, pseudoephedrine hcl, dextromethorphan hbr · PSEUDOEPHEDRINE HYDROCHLORIDE 30 mg/1; GUAIFENESIN 200 mg/1; ACETAMINOPHEN 325 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/1 · Capsule, Liquid Filled · Patheon Softgels Inc.
NDC 10888-8269-01 · 5000 CAPSULE, LIQUID FILLED in 1 BOX · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Opioid Analgesic REMS Shared System REMS
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of acetaminophen, guaifenesin, pseudoephedrine hcl, dextromethorphan hbr (Capsule, Liquid Filled)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Patheon Softgels Inc. | PSEUDOEPHEDRINE HYDROCHLORIDE 30 mg/1; GUAIFENESIN 200 mg/1; ACETAMINOPHEN 325 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/1 | Aug 20, 2026 | Sep 3, 2026 |
| The Procter & Gamble Manufacturing Company | ACETAMINOPHEN 325 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/1; GUAIFENESIN 200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Softgels Inc. | PSEUDOEPHEDRINE HYDROCHLORIDE 325 mg/1; GUAIFENESIN 10 mg/1; ACETAMINOPHEN 200 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 30 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Patheon Softgels Inc. | ACETAMINOPHEN 325 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/1; GUAIFENESIN 200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 30 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "acetaminophen, guaifenesin, pseudoephedrine hcl, dextromethorphan hbr — NDC 10888-8269-01," retrieved September 3, 2026, https://drugdashboards.com/drug/10888826901.
Free to cite with attribution — see how the data is put together.